CrossrefInfokarte
233 | S1608: RANDOMIZED PHASE II TRIAL COMPARING LENALIDOMIDE/OBINUTUZUMAB AND UMBRALISIB/OBINUTUZUMAB WITH CHEMOIMMUNOTHERAPY IN EARLY PROGRESSING FOLLICULAR LYMPHOMA (POD24)
Hematological Oncology · 2025-06 · 43 (S3)
DOI: 10.1002/hon.70094_233 ↗Abstract
Kein Abstract verfügbar.
EUVIMED